Brief: AnaptysBio Q4 Net Income USD -21.784 Million
27/02/2025 21:15
Feb 27 (Reuters) - AnaptysBio Q4 operating expenses USD 52.783 million. Q4 income from operations USD -9.67 million Q4 collaboration revenue USD 43.113 million
Recent news on AnaptysBio
See all newsU.S. RESEARCH ROUNDUP- Applied Materials, NVIDIA, Thermo Fisher Scientific
AnaptysBio's Q1 collaboration revenue falls, net loss widens
Brief: AnaptysBio Q1 Net Income USD -52.884 Million
Brief: Anaptys Appoints Chris Murphy As Chief Financial Officer And Owen Hughes To Board Of Directors
Brief: GSK Says Unit Tesaro's Claim For Declaratory Judgment Against Anaptysbio Unchanged